Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2-G4-kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Olendalizumab Biosimilar - Anti-C5 mAb - Research Grade |
|---|---|
| Source | CAS 1337966-73-0 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Olendalizumab,ALXN1007,C5,anti-C5 |
| Reference | PX-TA1406 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-G4-kappa |
| Clonality | Monoclonal Antibody |
Olendalizumab has been investigated for the treatment of Graft-versus-host disease, Antiphospholipid syndrome.
Immobilized Human C5 recombinant protein (cat. No. PX-P5117) at 0.5µg/mL (100µL/well) can bind Olendalizumab Biosimilar - Anti-C5 mAb (cat. No. PX-TA1406) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 141.6M.
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.